DISUSUN OLEH:
Abdullah Fadli Alhaddad I1011211031
Muhamad Hasbi I1011211072
Jovincent Arvan I1011211101
1. Bodaghi B, Brézin AP, Weber M, et al. Real-Life Efficacy, Safety, and Use of
Dexamethasone Intravitreal Implant in Posterior Segment Inflammation Due to Non-
infectious Uveitis (LOUVRE 2 Study). Ophthalmol Ther. 2022;11(5):1775-1792.
doi:10.1007/s40123-022-00525-8
2. Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann
BD, et al. Pharmacokinetics and pharmacodynamics of a sustained-release
dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2011 Jan;52(1):80–6.
3. Halodoc. Vitamins & Supplements [Internet]. halodoc. [cited 2024 Feb 29]. Available
from: https://www.halodoc.com/obat-dan-vitamin/kategori/vitamin-dan-suplemen-
1/suplemen-khusus/mata
4. Öhnell HM, Andreasson S, Gränse L. Dexamethasone Eye Drops for the Treatment of
Retinopathy of Prematurity. Ophthalmol Retina. 2022 Feb;6(2):181-182.
5. Self JE, Taylor R, Solebo AL, et al. Cataract management in children: a review of the
literature and current practice across five large UK centres. Eye (Lond). 2020
Dec;34(12):2197-2218.
6. Polymyxin B. MAXITROLTM Eye Drops [Internet]. Govt.nz. [cited 2024 Feb 29].
Available from: https://www.medsafe.govt.nz/consumers/cmi/m/Maxitrol.pdf